Ovarian cancer

A genetic study has found evidence to suggest that women who take statins in the long term could be less likely to develop ovarian cancer.

NICE has made olaparib (Lynparza), a targeted cancer drug, more widely available for people with ovarian cancer on the NHS in England.

A targeted cancer drug has been approved for use on the NHS in Scotland for patients with newly diagnosed ovarian cancer that’s responded to chemotherapy.

A targeted treatment for advanced ovarian cancer has been approved for use on the NHS in England and will be paid for by the Cancer Drugs Fund.

A targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.

A targeted drug for advanced ovarian cancer will be more widely available for certain patients on the NHS in England.

People who are obese now outnumber people who smoke two to one in the UK, and excess weight trumps smoking as the leading cause of four different cancer types.

Scientists have discovered that immune cells play a role in helping ovarian cancer cells to spread in mice.

A technique to get more information from the blood of cancer patients than previously possible has been developed.

A drug could help slow the progression of some advanced ovarian cancers and extend the time that patients show no signs of disease, according to new research.